Literature DB >> 22305240

Microsatellite instability status does not predict total lymph node or negative lymph node retrieval in stage III colon cancer.

Erin MacQuarrie1, Thomas Arnason, Jennette Gruchy, Sen Yan, Arik Drucker, Weei-Yuarn Huang.   

Abstract

The relationship between higher total lymph node resection number in colorectal cancer resection specimens and improved overall survival is well known. Recent studies describe an association between a high rate of microsatellite instability and a high total lymph node count in colorectal cancer. Higher lymph node retrieval may potentially explain the improved survival seen in cancers with microsatellite instability. We investigate whether these associations can be validated in a cohort of American Joint Committee on Cancer stage III colon cancers. Medical records from 200 cases of stage III colon cancer resection specimens were reviewed, and sufficient tissue was available for 168. Expression of DNA mismatch repair proteins was determined by immunohistochemistry, and microsatellite status, by polymerase chain reaction. The mean total lymph node count in cases with microsatellite instability versus microsatellite stable tumors (15.9 versus 16.9; P = .664) and the mean number of negative lymph nodes in each respective category (12.2 versus 13.6; P = .522) were not significantly different. There was no difference between microsatellite stable cases and cases with microsatellite instability when total lymph node counts (P = .953) or negative lymph node counts (P = .381) were analyzed with respect to percentage of cases above and below the medians. This cohort of stage III colon cancers does not support a significant relationship between microsatellite status and a higher retrieval of total or negative lymph nodes. Although microsatellite instability is associated with improved overall survival in our cohort (P = .026), the reason for this does not appear to be related to higher numbers of retrieved lymph nodes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305240     DOI: 10.1016/j.humpath.2011.10.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  The association between microsatellite instability and lymph node count in colorectal cancer.

Authors:  Alexander Arnold; Matthias Kloor; Lina Jansen; Jenny Chang-Claude; Hermann Brenner; Moritz von Winterfeld; Michael Hoffmeister; Hendrik Bläker
Journal:  Virchows Arch       Date:  2017-05-23       Impact factor: 4.064

Review 2.  Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.

Authors:  James W T Toh; Kevin Phan; Faizur Reza; Pierre Chapuis; Kevin J Spring
Journal:  Int J Colorectal Dis       Date:  2021-02-18       Impact factor: 2.571

Review 3.  Non-surgical factors influencing lymph node yield in colon cancer.

Authors:  Patrick Wood; Colin Peirce; Jurgen Mulsow
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

Review 4.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

5.  Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers.

Authors:  Marianne Berg; Marianne Guriby; Oddmund Nordgård; Bjørn S Nedrebø; Terje C Ahlquist; Rune Smaaland; Satu Oltedal; Jon Arne Søreide; Hartwig Kørner; Ragnhild A Lothe; Kjetil Søreide
Journal:  Mol Med       Date:  2013-09-10       Impact factor: 6.354

6.  Clinical implications of microsatellite instability in T1 colorectal cancer.

Authors:  Jeonghyun Kang; Hak Woo Lee; Im-kyung Kim; Nam Kyu Kim; Seung-Kook Sohn; Kang Young Lee
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

Review 7.  Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.

Authors:  Angelika Copija; Dariusz Waniczek; Andrzej Witkoś; Katarzyna Walkiewicz; Ewa Nowakowska-Zajdel
Journal:  Int J Mol Sci       Date:  2017-01-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.